Maintain ACN at $183 without fresh capital; scale adds only into $152-$169 with volume confirmation
The Hold at $183 threads the prior decision pattern: avoiding conviction-overload Buy failures (Aug 12 at $180), passive drift alpha leakage (Aug 13/14), and premature Underweight calls that underestimate the structural floor (Aug 7/10/18). The $152-$169 scaling zone represents the convergence where the aggressive analyst's structural floor (14.6x P/E on 24% ROE with $12B FCF and $10B/yr capital return) and conservative analyst's technical caution (declining 200 SMA overhead, unresolved June 18 gap-down) meet constructively. Bookings inflection >5% YoY or FY27 guidance acceleration warrants Overweight upgrade; forward EPS cut >5% from $14.68 consensus warrants Underweight downgrade.
| Position | Action |
|---|---|
| Price enters $152-$169 zone | Scale in with 5-7% of portfolio sizing, requiring volume confirmation at 50 SMA |
| Price moves to $200+ without confirmed close above 200 SMA ($203) on above-average volume | Trim position to lock in gains |
| Close below $118 (52-week low break) | Hard stop triggered — exit position |
| Confirmed close below 50 SMA with 50M+ capitulation volume | Consider Underweight positioning |
Accenture is a high-quality compounder being mispriced by a market fixated on AI-narrow leadership, offering a rare combination of deep valuation discount (50% below historical averages), elite returns (24.4% ROE, 16.5% FCF margins), and accelerating capital returns (~$10B annually) that make waiting for confirmation the most expensive decision an investor can make.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $174.97 | bullish |
| 50 SMA | $152.22 | bullish |
| 200 SMA | $203.15 | bearish |
| RSI (14) | 66.77 | neutral |
| MACD Line | 7.67 | bullish |
| MACD Signal | 7.46 | bullish |
| MACD Histogram | +0.20 | neutral |
| Bollinger Upper Band | $191.78 | neutral |
| Bollinger Middle Band | $169.01 | neutral |
| Bollinger Lower Band | $146.24 | neutral |
| ATR (14) |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
ACN's valuation represents a 50% discount to historical averages for a business maintaining elite financial metrics.
↩ rebuts: “Zacks bearish framing and Simply Wall St. DCF premium argument”
EV: +20% to +26% · concedes: The 200 SMA at $203.15 remains declining and presents a real technical ceiling near-term; RSI at 66.77 is genuinely elevated and may require consolidation before next leg up; Q4 FY25 and Q1 FY26 restructuring charges ($922M combined) do indicate the business model required material repositioning; AI-narrow leadership could persist longer than historical rotations suggest, delaying multiple expansion
ACN is cheap for a reason—decelerating growth, AI commoditization, and institutional capitulation signal further downside, not a coiled spring. The market is correctly re-rating the multiple to match low-single-digit revenue growth.
· concedes: ACN's 14.6x P/E is low (admitted); Dividend is real and 3x covered by FCF (admitted); Capital returns of ~$10B/year are substantial (admitted); Capital returns argument is the bull case's strongest point (narrowed rebuttal)
→ vs conservative: Conservative 'don't add at $183' conclusion misses that the structural floor is compelling enough to act now rather than wait for technical resistance to resolve
→ vs conservative: Conservative view is the one taking hidden risk — the risk of watching the stock rip to $220 while waiting for confirmation
→ vs neutral: 'Wait for confirmation' routine (200 SMA flattening, MACD confirmation, breakout above $203) will result in paying $220 for the same name debated at $183
→ vs neutral: Macro setup (Fed holding rates, 8% recession odds, weakening dollar, falling yields) is improving weekly — waiting for 'perfect' foregoes quality compounder opportunity
→ vs neutral: The math doesn't work for patience if measuring in real returns when a 20% opportunity cost is at stake
→ vs aggressive: Bearish narrative treats ACN as AI narrow leadership casualty (ACN down, INOD up 40%) but this compares a $73B revenue fortress to a $1.5B revenue data services company with customer concentration risk
→ vs aggressive: Bond market giving 3.77% yield treats ACN like junk credit, but equity market treating quality as worthless ignores that both cannot be right
| $8.14 |
| neutral |
Support: 174.97 · 169.01 · 152.22 · 146.24 | Resistance: 191.78 · 203.15
ACN exhibits a high-conflict transitional state with strong medium-term uptrend but bearish long-term structure. Price at $183.17 holds above 10 EMA ($174.97) and 50 SMA ($152.22) but remains below the declining 200 SMA ($203.15). RSI recovered from oversold (20.01 on Jun-22) to 66.77 but approaches overbought at 70.64 on Aug-12. MACD crossed bullish in late July but histogram at +0.20 indicates stalling momentum — price makes new recovery highs while MACD line has flattened over 5 sessions (8.65 → 7.67). Bollinger Bands show price in upper half (bullish) with upper band at $191.78 as near-term resistance. ATR of $8.14 indicates elevated 4.4% daily volatility. Asymmetric risk-reward: +11% upside to $200 SMA, –8% downside to $169 support, –17% downside to $152. Existing holders should protect profits with trailing stops near $170. Fresh capital entry at current levels carries unfavorable odds given stalling momentum and unconfirmed long-term trend reversal.
Market Cap
$112.09 billion
Shares Outstanding (diluted)
~615.6 million
Beta
1.074
Book Value per Share
$52.12
P/E (TTM)
14.63
Forward P/E
12.49
PEG Ratio
1.29
P/B
3.51
Dividend Yield
3.77%
EPS (TTM)
$12.52
Forward EPS
$14.67
Revenue (TTM)
$73.10B
Gross Profit
$23.40B
Gross Margin
32.0%
EBITDA
$12.94B
EBITDA Margin
17.7%
Net Income
$7.79B
Net Margin
10.66%
Operating Margin
16.96%
Return on Equity
24.41%
Return on Assets
10.90%
Free Cash Flow (TTM)
$12.09B
FCF Margin
~16.5%
Total Assets
$68.81B
Cash & Equivalents
$10.17B
Short-term Investments
$0.006B
Goodwill & Intangibles
$27.82B
Net PP&E
$4.59B
Total Debt
$8.39B
Long-Term Debt
$5.03B
Net Debt Position
Net Cash ~$1.8B
Stockholders' Equity
$31.89B
Working Capital
$7.33B
Current Ratio
1.34
52-Week High
$291.09
52-Week Low
$118.15
50-Day MA
$152.72
200-Day MA
$206.73
Price vs 200-DMA
-26%
Annual Capital Returns
~$10B (~9% of market cap)
Strengths
Concerns
BUY — Accenture presents a compelling risk-reward at 14.6x trailing earnings with a 3.77% dividend yield, supported by $12.09B in TTM free cash flow and industry-leading capital returns of ~$10B annually. The fortress balance sheet (net cash ~$1.8B) and 24.41% ROE demonstrate structural competitive advantages despite low single-digit revenue growth. Recent restructuring charges ($922M) position the firm for margin expansion in FY27, while the ~26% discount to the 200-day moving average reflects overly bearish sentiment on AI disruption that undervalues ACN's pivot to higher-value AI/data engineering work.
Macro: Soft-landing continuity with declining recession odds (US 8%, UK 10%, Japan 31%); Fed on hold with minimal near-term cut probability (1% Sept, 4% Oct, 14% Dec); Treasury expanded long-bond buybacks driving bull-steepening; dollar weakening; oil elevated at ~$92 on Hormuz geopolitical risk. Macro environment broadly supportive for defensive large-caps but ACN suffering from AI-trade concentration away from traditional consulting names.